BBC (Seroxat) is a dirty whore - willing to sell herself to the highest bidder

There was something fishy about this Panorama programme.



https://groups.google.com/group/uk.politics.misc/browse_thread/thread/56648ce8d1c32d22/96b278dc9e886023?hl=en&ie=UTF-8&q=Shelley+Jofre


The clinical researcher that the BBC interviewed assidiously
avoided mentioning the names of the other SSRIs that he had
researched even though he had found that those rival drugs had
similar profiles of adverse reactions. That to me spoke volumes.

I too known nothing about paroxetine, although I understand that
the side-effects of each SSRI are virtually indistinguishable.


Maybe the BBC, in broadcasting this vehemently anti-Seroxat programme,
was doing it as a service for Eli Lilly, the manufacturers of Prozac,
the main rival to Seroxat?


In damaging Seroxat, by explicitly attributing all these problems
specifically to it and not its rival drugs, was intended to increase
prescriptions for Prozac et al...


I don't think anyone as of late disputes that the BBC is a dirty whore -
willing to sell herself to the highest bidder and it is with that
in mind that I suspect, admittedly without any proof, that the BBC's
highest bidders this time around could well be GlaxoSmithKline's rival
companies....